Case 20 Thomas J. Giordano, M.D., Ph.D. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound and treated with…
Slide 1Malignant Pleural Effusion: Prevalence ~ 200,000 MPE / year in USA 1:4 Lung Cancer pt; 1:3 Breast; 9:10 Mesothelioma ~ 100,000 MPE from Lung Cancer / yr in Europe…
Cancer Drugs Cancer Drugs By: Savannah Denney What is cancer? The disease caused by an uncontrolled division of abnormal cells in a part of the body. A maligant growth or…
PowerPoint Presentation 1 Pt. assessment A.Alsagheir -2015 Pt. assessment A.Alsagheir -2015 دورة طب الشيخوخة 3/31- 2015/4/2 HOME MEDICAL CARE Patient Criteria…
âI canât breathâ: The Challenge of Dyspnea âI canât breatheâ: The Challenge of Dyspnea Comprehensive Approach to Dyspnea Management Pawandeep Brar Palliative Care Physician…
ERS/EACTS statement on the management of malignant pleural effusionsAnna C. Bibby1,2, Patrick Dorn3, Ioannis Psallidas4, Jose M. Porcel5, Julius Janssen6, Marios Froudarakis7,
Yataco10_05854 CLEVELAND CL IN IC JOURNAL OF MEDICINE VOLUME 72 • NUMBER 10 OCTOBER 2005 JOSÉ C. YATACO, MD Department of Pulmonary and Critical Care Medicine,